Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response

FASEB Journal

Volumn 29, Issue 2, 2015, Pages 636-649

  Van Stijn, Caroline M W ^a   Kim, Jason ^a   Lusis, Aldons J ^b   Barish, Grant D ^c   Tangirala, Rajendra K ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Adipokines; Inflammation; Macrophage activation; Metabolic disorder; Nuclear receptors

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LIVER X RECEPTOR ALPHA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; ADIPONECTIN RECEPTOR 1, MOUSE; ADIPONECTIN RECEPTOR 2, MOUSE; ADIPOR1 PROTEIN, HUMAN; ADIPOR2 PROTEIN, HUMAN; CYTOKINE; LIVER X RECEPTOR; ORPHAN NUCLEAR RECEPTOR;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW; CELL POLARITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; ATHEROSCLEROSIS; C57BL MOUSE; CELL LINE; CYTOLOGY; GENE EXPRESSION REGULATION; INFLAMMATION; INSULIN RESISTANCE; METABOLISM; MONOCYTE;

ADIPONECTIN; ANIMALS; ATHEROSCLEROSIS; CELL LINE; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-10; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; ORPHAN NUCLEAR RECEPTORS; PHENOTYPE; RECEPTORS, ADIPONECTIN;

EID: 84930947645     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-253831     Document Type: Article

References (61)

1. Friedman, J. M. (2000) Obesity in the new millennium. Nature 404, 632-634
2. Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., and Chen, H. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821-1830
3. Neels, J. G., and Olefsky, J. M. (2006) Inflamed fat: what starts the fire? J. Clin. Invest. 116, 33-35
4. Ouchi, N., Parker, J. L., Lugus, J. J., and Walsh, K. (2011) Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 11, 85-97
5. Scherer, P. E. (2006) Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55, 1537-1545
6. Berg, A. H., and Scherer, P. E. (2005) Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 96, 939-949
7. Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., Nishida, M., Kihara, S., Sakai, N., Nakajima, T., Hasegawa, K., Muraguchi, M., Ohmoto, Y., Nakamura, T., Yamashita, S., Hanafusa, T., and Matsuzawa, Y. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20, 1595-1599
8. Otake, H., Shite, J., Shinke, T., Watanabe, S., Tanino, Y., Ogasawara, D., Sawada, T., Hirata, K., and Yokoyama, M. (2008) Relation between plasma adiponectin, high-sensitivity C-reactive protein, and coronary plaque components in patients with acute coronary syndrome. Am. J. Cardiol. 101, 1-7
9. Yamaguchi, N., Argueta, J. G., Masuhiro, Y., Kagishita, M., Nonaka, K., Saito, T., Hanazawa, S., and Yamashita, Y. (2005) Adiponectin inhibits Toll-like receptor family-induced signaling. FEBS Lett. 579, 6821-6826
10. Okamoto, Y., Kihara, S., Ouchi, N., Nishida, M., Arita, Y., Kumada, M., Ohashi, K., Sakai, N., Shimomura, I., Kobayashi, H., Terasaka, N., Inaba, T., Funahashi, T., and Matsuzawa, Y. (2002) Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106, 2767-2770
11. Takemura, Y., Ouchi, N., Shibata, R., Aprahamian, T., Kirber, M. T., Summer, R. S., Kihara, S., and Walsh, K. (2007) Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J. Clin. Invest. 117, 375-386
12. Kumada, M., Kihara, S., Ouchi, N., Kobayashi, H., Okamoto, Y., Ohashi, K., Maeda, K., Nagaretani, H., Kishida, K., Maeda, N., Nagasawa, A., Funahashi, T., and Matsuzawa, Y. (2004) Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 109, 2046-2049
13. Wolf, A. M., Wolf, D., Rumpold, H., Enrich, B., and Tilg, H. (2004) Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem. Biophys. Res. Commun. 323, 630-635
14. Lovren, F., Pan, Y., Quan, A., Szmitko, P. E., Singh, K. K., Shukla, P. C., Gupta, M., Chan, L., Al-Omran, M., Teoh, H., and Verma, S. (2010) Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages. Am. J. Physiol. Heart Circ. Physiol. 299, H656-H663
15. Mandal, P., Pratt, B. T., Barnes, M., McMullen, M. R., and Nagy, L. E. (2011) Molecular mechanism for adiponectin-dependent M2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin. J. Biol. Chem. 286, 13460-13469
16. Ohashi, K., Parker, J. L., Ouchi, N., Higuchi, A., Vita, J. A., Gokce, N., Pedersen, A. A., Kalthoff, C., Tullin, S., Sams, A., Summer, R., and Walsh, K. (2010) Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J. Biol. Chem. 285, 6153-6160
17. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35
18. Sica, A., and Mantovani, A. (2012) Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122, 787-795
19. Gordon, S., and Taylor, P. R. (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964
20. Mosser, D. M., and Edwards, J. P. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969
21. Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., Locati, M., Mantovani, A., Martinez, F. O., Mege, J. L., Mosser, D. M., Natoli, G., Saeij, J. P., Schultze, J. L., Shirey, K. A., Sica, A., Suttles, J., Udalova, I., van Ginderachter, J. A., Vogel, S. N., and Wynn, T. A. (2014) Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41, 14-20
22. Lumeng, C. N., Bodzin, J. L., and Saltiel, A. R. (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184
23. Spencer, M., Yao-Borengasser, A., Unal, R., Rasouli, N., Gurley, C. M., Zhu, B., Peterson, C. A., and Kern, P. A. (2010) Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. Am. J. Physiol. Endocrinol. Metab. 299, E1016-E1027
24. Gordon, S. (2007) The macrophage: past, present and future. Eur. J. Immunol. 37 (Suppl 1), S9-S17
25. Savill, J., Dransfield, I., Gregory, C., and Haslett, C. (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2, 965-975
26. Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., and Tsunoda, M., (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762-769
27. Holland, W. L., and Scherer, P. E. (2009) PAQRs: a counter-acting force to ceramides? Mol. Pharmacol. 75, 740-743
28. Tsuchida, A., Yamauchi, T., Takekawa, S., Hada, Y., Ito, Y., Maki, T., and Kadowaki, T. (2005) Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination. Diabetes 54, 3358-3370
29. Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., Murakami, K., Ohteki, T., Uchida, S., Takekawa, S., Waki, H., Tsuno, N. H., Shibata, Y., Terauchi, Y., Froguel, P., Tobe, K., Koyasu, S., Taira, K., Kitamura, T., Shimizu, T., Nagai, R., and Kadowaki, T. (2011) Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat. Med. 17, 55-63
30. Bjursell, M., Ahnmark, A., Bohlooly-Y, M., William-Olsson, L., Rhedin, M., Peng, X. R., Ploj, K., Gerdin, A. K., Arnerup, G., Elmgren, A., Berg, A. L., Oscarsson, J., and Lindén, D. (2007) Opposing effects of adiponectin receptors 1 and 2 on energy metabolism. Diabetes 56, 583-593
31. Liu, Y., Michael, M. D., Kash, S., Bensch, W. R., Monia, B. P., Murray, S. F., Otto, K. A., Syed, S. K., Bhanot, S., Sloop, K. W., Sullivan, J. M., and Reiffel-Miller, A. (2007) Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes. Endocrinology 148, 683-692
32. Yamauchi, T., Nio, Y., Maki, T., Kobayashi, M., Takazawa, T., Iwabu, M., Okada-Iwabu, M., Kawamoto, S., Kubota, N., Kubota, T., Ito, Y., Kamon, J., Tsuchida, A., Kumagai, K., Kozono, H., Hada, Y., Ogata, H., Tokuyama, K., Tsunoda, M., Ide, T., Murakami, K., Awazawa, M., Takamoto, I., Froguel, P., Hara, K., Tobe, K., Nagai, R., Ueki, K., and Kadowaki, T. (2007) Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 13, 332-339
33. Inukai, K., Nakashima, Y., Watanabe, M., Takata, N., Sawa, T., Kurihara, S., Awata, T., and Katayama, S. (2005) Regulation of adiponectin receptor gene expression in diabetic mice. Am. J. Physiol. Endocrinol. Metab. 288, E876-E882
34. Staiger, H., Kaltenbach, S., Staiger, K., Stefan, N., Fritsche, A., Guirguis, A., Péterfi, C., Weisser, M., Machicao, F., Stumvoll, M., and Häring, H. U. (2004) Expression of adiponectin receptor mRNA in human skeletal muscle cells is related to in vivo parameters of glucose and lipid metabolism. Diabetes 53, 2195-2201
35. Tan, G. D., Debard, C., Funahashi, T., Humphreys, S. M., Matsuzawa, Y., Frayn, K. N., Karpe, F., and Vidal, H. (2005) Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy. Diabetologia 48, 1585-1589
36. Chinetti, G., Zawadski, C., Fruchart, J. C., and Staels, B. (2004) Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR. Biochem. Biophys. Res. Commun. 314, 151-158
37. Kollias, A., Tsiotra, P. C., Ikonomidis, I., Maratou, E., Mitrou, P., Kyriazi, E., Boutati, E., Lekakis, J., Economopoulos, T., Kremastinos, D. T., Dimitriadis, G., and Raptis, S. A. (2011) Adiponectin levels and expression of adiponectin receptors in isolated monocytes from overweight patients with coronary artery disease. Cardiovasc. Diabetol. 10, 14
38. Weigert, J., Neumeier, M., Wanninger, J., Wurm, S., Kopp, A., Schober, F., Filarsky, M., Schäffler, A., Zeitoun, M., Aslanidis, C., and Buechler, C. (2008) Reduced response to adiponectin and lower abundance of adiponectin receptor proteins in type 2 diabetic monocytes. FEBS Lett. 582, 1777-1782
39. Luo, N., Chung, B. H., Wang, X., Klein, R. L., Tang, C. K., Garvey, W. T., and Fu, Y. (2013) Enhanced adiponectin actions by overexpression of adiponectin receptor 1 in macrophages. Atherosclerosis 228, 124-135
40. Chawla, A., Barak, Y., Nagy, L., Liao, D., Tontonoz, P., and Evans, R. M. (2001) PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 7, 48-52
41. Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J., and Tontonoz, P. (2003) Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9, 213-219
42. Ezekowitz, R. A., Hill, M., and Gordon, S. (1986) Interferon alpha/beta selectively antagonises down-regulation of mannosylfucosyl receptors on activated macrophages by interferon gamma. Biochem. Biophys. Res. Commun. 136, 737-744
43. Ivashkiv, L. B. (2011) Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states. Eur. J. Immunol. 41, 2477-2481
44. Stout, R. D., Jiang, C., Matta, B., Tietzel, I., Watkins, S. K., and Suttles, J. (2005) Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 175, 342-349
45. Barish, G. D., Yu, R. T., Karunasiri, M., Ocampo, C. B., Dixon, J., Benner, C., Dent, A. L., Tangirala, R. K., and Evans, R. M. (2010) Bcl-6 and NF-kappaB cistromes mediate opposing regulation of the innate immune response. Genes Dev. 24, 2760-2765
46. Tian, L., Luo, N., Zhu, X., Chung, B. H., Garvey, W. T., and Fu, Y. (2012) Adiponectin-AdipoR1/2-APPL1 signaling axis suppresses human foam cell formation: differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses. Atherosclerosis 221, 66-75
47. Okada-Iwabu, M., Yamauchi, T., Iwabu, M., Honma, T., Hamagami, K., Matsuda, K., Yamaguchi, M., Tanabe, H., Kimura-Someya, T., Shirouzu, M., Ogata, H., Tokuyama, K., Ueki, K., Nagano, T., Tanaka, A., Yokoyama, S., and Kadowaki, T. (2013) A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature 503, 493-499
48. Yamauchi, T., and Kadowaki, T. (2013) Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell Metab. 17, 185-196
49. Folco, E. J., Rocha, V. Z., López-Ilasaca, M., and Libby, P. (2009) Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10. J. Biol. Chem. 284, 25569-25575
50. Thakur, V., Pritchard, M. T., McMullen, M. R., and Nagy, L. E. (2006) Adiponectin normalizes LPS-stimulated TNF-alpha production by rat Kupffer cells after chronic ethanol feeding. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G998-G1007
51. Wulster-Radcliffe, M. C., Ajuwon, K. M., Wang, J., Christian, J. A., and Spurlock, M. E. (2004) Adiponectin differentially regulates cytokines in porcine macrophages. Biochem. Biophys. Res. Commun. 316, 924-929
52. van Stijn, C. M., Kim, J., Barish, G. D., Tietge, U. J., and Tangirala, R. K. (2014) Adiponectin expression protects against angiotensin II-mediated inflammation and accelerated atherosclerosis. PLoS ONE 9, e86404
53. Joseph, S. B., Bradley, M. N., Castrillo, A., Bruhn, K. W., Mak, P. A., Pei, L., Hogenesch, J., O'connell, R. M., Cheng, G., Saez, E., Miller, J. F., and Tontonoz, P. (2004) LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119, 299-309
54. Cheng, X., Folco, E. J., Shimizu, K., and Libby, P. (2012) Adiponectin induces pro-inflammatory programs in human macrophages and CD4+ T cells. J. Biol. Chem. 287, 36896-36904
55. Park, P. H., McMullen, M. R., Huang, H., Thakur, V., and Nagy, L. E. (2007) Short-term treatment of RAW264.7 macrophages with adiponectin increases tumor necrosis factor-alpha (TNF-alpha) expression via ERK1/2 activation and Egr-1 expression: role of TNF-alpha in adiponectin-stimulated interleukin-10 production. J. Biol. Chem. 282, 21695-21703
56. Abke, S., Neumeier, M., Weigert, J., Wehrwein, G., Eggenhofer, E., Schäffler, A., Maier, K., Aslanidis, C., Schölmerich, J., and Buechler, C. (2006) Adiponectin-induced secretion of interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1, CCL2) and interleukin-8 (IL-8, CXCL8) is impaired in monocytes from patients with type I diabetes. Cardiovasc. Diabetol. 5, 17
57. Rovin, B. H., and Song, H. (2006) Chemokine induction by the adipocyte-derived cytokine adiponectin. Clin. Immunol. 120, 99-105
58. Fantuzzi, G. (2008) Adiponectin and inflammation: consensus and controversy. J. Allergy Clin. Immunol. 121, 326-330
59. Ehling, A., Schäffler, A., Herfarth, H., Tarner, I. H., Anders, S., Distler, O., Paul, G., Distler, J., Gay, S., Schölmerich, J., Neumann, E., and Müller-Ladner, U. (2006) The potential of adiponectin in driving arthritis. J. Immunol. 176, 4468-4478
60. Ogunwobi, O. O., and Beales, I. L. (2006) Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells. Regul. Pept. 134, 105-113
61. Park, S. H., Park-Min, K. H., Chen, J., Hu, X., and Ivashkiv, L. B. (2011) Tumor necrosis factor induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages. Nat. Immunol. 12, 607-615